| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c1fd459bd0eefb367da0850dfd4842f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16016087fdffb450971d85798d4050fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe9cbfc01d3b2402a5b2435f2111549c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cb97f0c052e05365ddcde7da2a0a200 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451d858af39baf6ccb56d6615491407a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a6d6e4e47aba42a706ba89a18bb4579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfc9b919b561a703200d64a1a98f71b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73bfd3799dfcd0919204c0f6862d71f |
| publicationDate |
2012-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012053158-A1 |
| titleOfInvention |
Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration |
| abstract |
The present invention refers to a pharmaceutical preparation comprising an ionic type complex of acetyl salicylic acid and L-glutamic acid for use in the prevention or reduction of side-effects on stomach tissue associated with an oral administration of acetyl salicylic acid. |
| priorityDate |
2009-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |